CUADRO DEFINITIVO LICITACIÓN PÚBLICA 01/2009

Size: px
Start display at page:

Download "CUADRO DEFINITIVO LICITACIÓN PÚBLICA 01/2009"

Transcription

1 Artritis 1 Abatacept 250 mg vial x $ 2.033,08 $ ,87 Artritis 2 Adalimumab 40 mg jga prell x $ 5.371,03 $ ,01 Artritis 3 Celecoxib 200 mg comp X 10 0 $ 9,07 $ 0,00 Artritis 4 Deflazacort 6 mg comp x 10 4 $ 12,33 $ 49,33 Artritis 5 Deflazacort 6 mg comp x $ 23,95 $ 934,22 Artritis 6 Deflazacort 30 mg comp x 10 0 $ 65,00 $ 0,00 Artritis 7 Deflazacort 30 mg comp x 20 1 $ 114,70 $ 114,70 Artritis 8 Diclofenac 150 mg comp x 10 0 $ 0,00 $ 0,00 Artritis 9 Etanercept 25 mg amp x $ 2.996,00 $ ,00 Artritis 10 Etanercept 50 mg amp x $ 5.992,00 $ ,00 Artritis 11 Etoricoxib 60 mg x comp 28 1 $ 66,75 $ 66,75 Artritis 12 Etoricoxib 90 mg x comp $ 70,20 $ 4.914,00 Artritis 13 Hidroxicloroquina 200 mg comp x $ 59,99 $ 1.439,76 Artritis 14 Indometasina 75 mg comp x 20 2 $ 23,51 $ 47,02 Artritis 15 Indometasina 75 mg comp x 24 3 $ 35,02 $ 105,06 Artritis 16 Indometasina 75 mg comp x 50 1 $ 63,62 $ 63,62 Artritis 17 Indometasina 100 mg supos x 10 0 $ 30,22 $ 0,00 Artritis 18 Indometasina 100 mg supos x 30 0 $ 84,00 $ 0,00 Artritis 19 Infliximab 100 mg amp x 1 20 $ 4.894,00 $ ,00 Artritis 20 Leflunomida 20 mg comp x $ 72,25 $ ,75 Artritis 21 Meloxicam 7,5 mg comp x 10 0 $ 0,00 $ 0,00 Artritis 22 Meloxicam 15 mg comp x $ 7,70 $ 315,70 Artritis 23 Meloxicam 15 mg comp x 20 5 $ 15,35 $ 76,75 Artritis 24 Meloxican 15 mg Amp x 3 0 $ 0,00 $ 0,00 Artritis 25 Metilprednisona 8 mg comp x $ 21,00 $ 1.827,00 Artritis 26 Metotrexato 10 mg comp x $ 19,30 $ 2.644,10 Artritis 27 Metotrexato 15 mg amp x $ 28,70 $ 4.735,50 Artritis 28 Metotrexato 15 mg x 15 Comp 0 $ 0,00 $ 0,00 Artritis 29 Metotrexato 7,5 mg comp x $ 18,29 $ 749,89 Artritis 30 Metotrexato 20 mg amp x 4 22 $ 31,31 $ 688,82 Artritis 31 Naproxeno 500 mg comp x $ 23,40 $ 3.884,40 Artritis 32 Nimesulida 200 mg x 15 0 $ 15,96 $ 0,00 Artritis 33 Nimesulida 200 mg x 30 4 $ 30,78 $ 123,12 Artritis 34 Prednisona 5 mg comp x $ 18,90 $ 3.099,60 Artritis 35 Rituximab 500 mg/50 ml fco amp 24 $ 9.037,57 $ ,59 Esclerosis 1 Interferon beta IM jga prell x 1 ml x 4 36 $ 9.800,00 $ ,00 Esclerosis 2 Interferon beta 8 MUI vial x 15 + jga prell x 15 c/dil 30 $ 8.900,00 $ ,00 Esclerosis 3 Acetato de Glatimer - 1 jga prell x $ 9.510,46 $ ,75 CUADRO DEFINITIVO LIC. PÚB. 01/2009-1/13

2 Esclerosis 4 Interferon beta 22 mcg jga prell x 12 x 0,5 ml 0 $ 7.649,40 $ 0,00 Esclerosis 5 Interferon beta 44 mcg jga prell x 12 x 0,5 ml 6 $ 7.824,29 $ ,72 Esclerosis 6 Interferon beta 6 MUI jga prell x 12 8 $ ,00 $ ,00 Esclerosis 7 Interferon beta 12 MUI jga prell x $ ,00 $ ,00 Esclerosis 8 Rilusol 50 mg comp x $ 1.705,38 $ ,56 Esclerosis 9 Rilusol 50 mg comp x $ 2.132,91 $ ,92 HIV 1 Abacavir + Lamivudina + Zidovudina comp rec x $ 877,00 $ ,00 HIV 2 Abacavir + Lamivudina comp x $ 1.323,52 $ ,70 HIV 3 Abacavir 300 mg comp rec. x 60 0 $ 190,00 $ 0,00 HIV 4 Anfotericina B liposomal 0 $ 1.159,00 $ 0,00 HIV 5 Atazanavir 150 mg x 60 0 $ 0,00 $ 0,00 HIV 6 Atazanavir 200 mg x $ 1.634,70 $ ,90 HIV 7 Atazanavir 300 mg comp x $ 1.634,70 $ ,90 HIV 8 Azacitidina 100 mg fco amp 35 $ 4.793,18 $ ,31 HIV 9 Didanosina 100 mg x 60 comp 0 $ 0,00 $ 0,00 HIV 10 Didanosina 125 mg x 30 comp 0 $ 0,00 $ 0,00 HIV 11 Didanosina 200 mg x 30 caps. 0 $ 220,34 $ 0,00 HIV 12 Didanosina 200 mg x 60 tab. 0 $ 0,00 $ 0,00 HIV 13 Didanosina 25 mg x 60 caps 0 $ 0,00 $ 0,00 HIV 14 Didanosina 250 mg x 30 caps 0 $ 279,51 $ 0,00 HIV 15 Didanosina 400 mg x 30 caps 11 $ 312,42 $ 3.436,59 HIV 16 Didanosina 50 mg x 60 0 $ 0,00 $ 0,00 HIV 17 Didanosina ped. Sol. Oral x 2 gr 0 $ 0,00 $ 0,00 HIV 18 Didanosina ped. Sol. Oral x 4 gr 0 $ 0,00 $ 0,00 HIV 19 Efavirenz 200 mg x 90 cap 0 $ 266,70 $ 0,00 HIV 20 Efavirenz 50 mg x 30 cap 0 $ 0,00 $ 0,00 HIV 21 Efavirenz 600 mg x 30 comp 175 $ 436,45 $ ,68 HIV 22 Famciclovir 125 mg x 10 comp 0 $ 0,00 $ 0,00 HIV 23 Famciclovir 500 mg x 21 comp 0 $ 0,00 $ 0,00 HIV 24 Famciclovir 500 mg x 7 comp 0 $ 0,00 $ 0,00 HIV 25 Fluconazol 200 mg comp x $ 125,68 $ 1.633,83 HIV 26 Fosamprenavir 700 mg x $ 1.268,04 $ ,58 HIV 27 Hidrocortisona comp x 30 0 $ 9,09 $ 0,00 HIV 28 Indinavir 200 mg x 360 cap 0 $ 0,00 $ 0,00 HIV 29 Indinavir 400 mg x 180 cap 6 $ 269,50 $ 1.617,00 HIV 30 Interferon Alfa 2 A 3 MUI jga. Prell x 1 0 $ 21,25 $ 0,00 HIV 31 Interferon Alfa 2 A 4,5 MUI fco amp x 1 0 $ 31,90 $ 0,00 HIV 32 Interferon Alfa 2 A 6 MUI jga prell x 1 0 $ 0,00 $ 0,00 CUADRO DEFINITIVO LIC. PÚB. 01/2009-2/13

3 HIV 33 Interferon Alfa 2 A 9 MUI jga prell x 1 0 $ 64,00 $ 0,00 HIV 34 Interferon Alfa 2 B + ribavirina 3 mui a x 3 + cap x 42 0 $ 0,00 $ 0,00 HIV 35 Interferon Alfa 2 B 3 MUI vial x 2 ml 0 $ 14,58 $ 0,00 HIV 36 Interferon Alfa 2 B 5 MUI vial x 2 ml 0 $ 23,40 $ 0,00 HIV 37 Interferon Alfa 2 B 10 MUI vial x 2 ml 0 $ 46,80 $ 0,00 HIV 38 Interferon Alfa 2 B 18 MUI aplic multid x 1 0 $ 713,00 $ 0,00 HIV 39 Interferon Alfa 2 B 30 MUI apl. Multidosis x 1 0 $ 1.245,00 $ 0,00 HIV 40 Interferon Alfa 2 B 60 MUI apl. Multidosis x 1 0 $ 2.490,00 $ 0,00 HIV 41 Interferon Alfa 2 B Pegilado 50 mcg vial x 1 0 $ 650,00 $ 0,00 HIV 42 Interferon Alfa 2 B Pegilado 80 mcg vial x 1 0 $ 1.361,00 $ 0,00 HIV 43 Interferon Alfa 2 B Pegilado 120 mcg vial x 1 0 $ 1.625,00 $ 0,00 HIV 44 Itroconazol comp x 4 0 $ 9,83 $ 0,00 HIV 45 Itroconazol comp x $ 32,13 $ 1.285,20 HIV 46 Itroconazol comp x 30 1 $ 53,68 $ 53,68 HIV 47 Lamivudina + Zidovudina comp rec x $ 79,80 $ 1.915,20 HIV 48 Lamivudina + Zidovudina comp x $ 390,52 $ ,58 HIV 49 Lamivudina 150 mg comp x $ 29,90 $ 2.541,50 HIV 50 Lamivudina 300 mg comp x $ 64,80 $ 0,00 HIV 51 Lamivudina Sus. x 240 ml 33 $ 128,00 $ 4.224,05 HIV 52 Leucovorina 15 mg comp x $ 7,11 $ 2.950,65 HIV 53 Nelfinavir 250 mg x 270 comp 14 $ 602,33 $ 8.432,63 HIV 54 Nevirapina 200 mg x 60 comp 17 $ 51,50 $ 875,50 HIV 55 Nevirapina 200 mg x 60 comp 3 $ 244,25 $ 732,75 HIV 56 Nevirapina 200 mg x 100 comp 0 $ 0,00 $ 0,00 HIV 57 Nevirapina Sus x 240 ml 0 $ 153,11 $ 0,00 HIV 58 Pegasys 180 mg amp x 1 0 $ 1.166,82 $ 0,00 HIV 59 Pirimetamina 25 mg comp x $ 23,39 $ 350,89 HIV 60 Prezista 300 mg comp x $ 3.745,15 $ 0,00 HIV 61 Ritonavir + lopinavir cap x $ 1.710,00 $ ,00 HIV 62 Ritonavir + lopinavir jbe.x 160 ml 0 $ 840,00 $ 0,00 HIV 63 Ritonavir 100 mg comp x $ 741,94 $ ,89 HIV 64 Sequinavir 200 mg comp x $ 0,00 $ 0,00 HIV 65 Sequinavir 500 mg comp x $ 1.457,47 $ ,65 HIV 66 Stavudina 15 mg x 60 comp 0 $ 0,00 $ 0,00 HIV 67 Stavudina 20 mg x 60 comp 0 $ 0,00 $ 0,00 HIV 68 Stavudina 30 mg x 60 comp 7 $ 48,61 $ 340,28 HIV 69 Stavudina 40 mg x 60 comp 5 $ 38,00 $ 190,00 HIV 70 Stavudina susp oral x 200 ml 0 $ 0,00 $ 0,00 CUADRO DEFINITIVO LIC. PÚB. 01/2009-3/13

4 HIV 71 Sulfametoxazol + trimetoprima comp x $ 23,91 $ 3.204,48 HIV 72 Tenofovir + Emtricitabina comp x $ 1.732,49 $ ,11 HIV 73 Viracept 50 mg polvo x 144 gr 0 $ 0,00 $ 0,00 HIV 74 Viracept 250 mg comp x $ 0,00 $ 0,00 HIV 75 Viread comp x $ 1.253,81 $ ,42 HIV 76 Zidovudina 100 mg cap x $ 69,11 $ 967,54 HIV 77 Zidovudina 200 mg amp x 1 0 $ 20,39 $ 0,00 HIV 78 Zidovudina fco x 240 ml 29 $ 50,92 $ 1.476,68 HIV 79 Zulfadiazina 500 mg comp x $ 22,95 $ 688,50 Inmuno 1 Azatioprina 50 mg comp x 25 0 $ 66,42 $ 0,00 Inmuno 2 Azatioprina 50 mg comp x $ 275,53 $ 0,00 Inmuno 3 Azatioprina 50 mg comp x $ 275,53 $ 0,00 Inmuno 4 Ciclosporina P/Microemulsión 10 mg x 60 cap (Sandimun) 12 $ 121,45 $ 1.457,35 Inmuno 5 Ciclosporina P/Microemulsión 25 mg x 50 cap (Sandimun) 23 $ 220,32 $ 5.067,36 Inmuno 6 Ciclosporina P/Microemulsión 50 mg x 50 cap (Sandimun) 19 $ 374,99 $ 7.124,75 Inmuno 7 Ciclosporina P/Microemulsión 100 mg x 50 cap (Sandimun) 29 $ 679,59 $ ,11 Inmuno 8 Ciclosporina P/Microemulsión Sol. Beb.x 50 ml (Sandimun) 21 $ 748,54 $ ,28 Inmuno 9 Daclizumab 25 mg / 5 ml amp x 1 (Zenapax) 0 $ 1.545,40 $ 0,00 Inmuno 10 Metilprednisona 4 mg comp x 20 (Cortipyren) 82 $ 13,73 $ 1.125,86 Inmuno 11 Metilprednisona 4 mg comp x 20 (Deltisona) 0 $ 9,67 $ 0,00 Inmuno 12 Metilprednisona 8 mg comp x 20 (Cortipyren) 0 $ 27,47 $ 0,00 Inmuno 13 Metilprednisona 8 mg comp x 20 (Deltisona) 0 $ 18,91 $ 0,00 Inmuno 14 Metilprednisona 40 mg comp x 20 (Cortipyren) 0 $ 72,60 $ 0,00 Inmuno 15 Metilprednisona 40 mg comp x 20 (Deltisona) 0 $ 50,26 $ 0,00 Inmuno 16 Micofelonato Mofetil 250 mg comp x 100 (Cellcept) 11 $ 378,00 $ 4.158,00 Inmuno 17 Micofelonato Mofetil 500 mg comp x 50 (Cellcept) 122 $ 388,09 $ ,64 Inmuno 18 Micofenolato Sódico 180 mg x 100 (Myfortic) 5 $ 591,86 $ 2.959,31 Inmuno 19 Micofenolato Sódico 360 mg x 100 (Myfortic) 23 $ 1.183,67 $ ,39 Inmuno 20 Sirulimus 1 mg comp x 60 (Rapamune) 17 $ 2.331,90 $ ,22 Inmuno 21 Sirulimus 2 mg comp x 60 (Rapamune) 0 $ 2.331,90 $ 0,00 Inmuno 22 Sirulimus sol.oral x 60 ml (Rapamune) 0 $ 2.363,70 $ 0,00 Inmuno 23 Solumedrol 500 mg amp x 1 0 $ 0,00 $ 0,00 Inmuno 24 Tacrolimus 0,5 mg x 50 cap (Prograf) 26 $ 425,95 $ ,70 Inmuno 25 Tacrolimus 1 mg x 100 cap (Prograf) 133 $ 1.287,03 $ ,99 Inmuno 26 Tacrolimus 5 mg x 50 cap (Prograf) 17 $ 3.259,27 $ ,59 Oncológico 1 Acitretina 10 mg comp x 30 0 $ 61,71 $ 0,00 Oncológico 2 Acitretina 25 mg comp x 30 2 $ 129,95 $ 259,89 Oncológico 3 Anastrozol 1 mg comp x $ 18,19 $ 7.421,52 CUADRO DEFINITIVO LIC. PÚB. 01/2009-4/13

5 Oncológico 4 Anastrozol 1 mg comp x $ 366,11 $ ,22 Oncológico 5 Anastrozol 1 mg comp x 30 0 $ 23,76 $ 0,00 Oncológico 6 Anastrozol 1 mg comp x 30 9 $ 106,53 $ 958,77 Oncológico 7 Aprepitan 125/80 mg comp x $ 293,11 $ ,21 Oncológico 8 Asparaginasa UI amp x 1 28 $ 363,53 $ ,78 Oncológico 9 Azatioprina 50 mg comp x $ 49,00 $ 196,00 Oncológico 10 Bevacizumab 100 mg/4 ml Vial x $ 2.460,22 $ ,83 Oncológico 11 Bevacizumab 400 mg/16 ml Vial x $ 8.960,24 $ ,53 Oncológico 12 Bicalutamida 50 mg comp x $ 32,40 $ 3.142,80 Oncológico 13 Bicalutamida 150 mg comp x $ 408,00 $ ,00 Oncológico 14 Bleomicina 15 mg fco amp x 1 x 10 ml 56 $ 38,00 $ 2.128,00 Oncológico 15 Bortezomib 3,5 mg vial x 10 ml x 1 48 $ 8.617,00 $ ,00 Oncológico 16 Busereline Depot 6,3 mg Kit x 1 50 $ 1.588,00 $ ,00 Oncológico 17 Busulfano grag x 25 0 $ 74,22 $ 0,00 Oncológico 18 Capecitabina 500 mg comp x $ 1.298,00 $ ,00 Oncológico 19 Carboplatino 50 mg amp x 1 71 $ 26,24 $ 1.863,32 Oncológico 20 Carboplatino 150 mg amp x $ 31,75 $ ,00 Oncológico 21 Carmustina 100 mg fco amp x 1 37 $ 355,66 $ ,42 Oncológico 22 Cetuximab 100 mg fco amp x $ 1.751,51 $ ,43 Oncológico 23 Ciclofosfamida 1 g amp x $ 20,98 $ 5.517,74 Oncológico 24 Ciclofosfamida 200 mg amp x $ 9,42 $ 1.337,64 Oncológico 25 Ciclosporina 10 mg caps x 50 0 $ 121,45 $ 0,00 Oncológico 26 Ciclosporina 25 mg caps.x 50 0 $ 220,32 $ 0,00 Oncológico 27 Ciclosporina 50 mg caps x 50 0 $ 374,99 $ 0,00 Oncológico 28 Ciclosporina 100 mg caps x 60 0 $ 679,58 $ 0,00 Oncológico 29 Ciclosporina 100 mg sol beb x 50 ml 0 $ 748,54 $ 0,00 Oncológico 30 Ciproterona 50 mg comp x $ 29,55 $ ,95 Oncológico 31 Ciproterona 50 mg comp x $ 129,00 $ 6.192,00 Oncológico 32 Ciproterona 50 mg comp x 50 8 $ 61,75 $ 494,00 Oncológico 33 Ciproterona 100 mg comp x 30 0 $ 98,80 $ 0,00 Oncológico 34 Ciproterona 100 mg comp x $ 148,20 $ ,20 Oncológico 35 Cisplatino 10 mg amp x 1 0 $ 10,80 $ 0,00 Oncológico 36 Cisplatino 50 mg amp x $ 23,76 $ 8.220,96 Oncológico 37 Cisplatino 100 mg amp x 1 0 $ 0,00 $ 0,00 Oncológico 38 Citarabina 1 g amp x 1 polvo liof. 133 $ 9,61 $ 1.278,40 Oncológico 39 Citarabina 100 mg amp polvo liof. 117 $ 7,49 $ 876,33 Oncológico 40 Citarabina 500 mg amp x 1 0 $ 29,01 $ 0,00 Oncológico 41 Cladribine amp x 1 30 $ 951,33 $ ,86 CUADRO DEFINITIVO LIC. PÚB. 01/2009-5/13

6 Oncológico 42 Cladribine amp x 7 0 $ 6.657,60 $ 0,00 Oncológico 43 Clorambucilo 2 mg comp x $ 115,68 $ 1.388,15 Oncológico 44 Clorambucilo 5 mg comp x 25 0 $ 0,00 $ 0,00 Oncológico 45 Dacarbazina 100 mg amp x 1 polvo liof. 17 $ 15,81 $ 268,77 Oncológico 46 Dacarbazina 200 mg amp x 1 polvo liof. 196 $ 20,32 $ 3.982,72 Oncológico 47 Dactinomicina 0,5 mg amp x 1 0 $ 99,77 $ 0,00 Oncológico 48 Dasatinib 20 mg comp x 60 0 $ 8.070,78 $ 0,00 Oncológico 49 Dasatinib 50 mg comp x $ ,80 $ ,58 Oncológico 50 Dasatinib 70 mg comp x 60 0 $ ,72 $ 0,00 Oncológico 51 Daunomicina 20 mg amp x 1 12 $ 43,80 $ 525,60 Oncológico 52 Deferasirox 125 mg comp x 28 0 $ 1.009,42 $ 0,00 Oncológico 53 Deferasinox 250 mg comp x 28 0 $ 2.018,83 $ 0,00 Oncológico 54 Deferasirox 500 mg comp x 28 0 $ 4.037,66 $ 0,00 Oncológico 55 Deflazacort 6 mg comp x 10 0 $ 12,33 $ 0,00 Oncológico 56 Deflazacort 30 mg comp x 10 0 $ 65,00 $ 0,00 Oncológico 57 Dexametasona 4 mg comp x $ 40,37 $ 686,29 Oncológico 58 Dexametasona 8 mg amp x $ 1,53 $ 817,02 Oncológico 59 Dietilestilbestrol 1 mg comp x 30 0 $ 126,40 $ 0,00 Oncológico 60 Docetaxel 20 mg amp x 1 53 $ 36,00 $ 1.908,00 Oncológico 61 Docetaxel 80 mg amp x $ 81,99 $ ,10 Oncológico 62 Docetaxel 80 mg amp x 1 0 $ 1.331,10 $ 0,00 Oncológico 63 Doxorubicina 10 mg amp x 1 0 $ 11,79 $ 0,00 Oncológico 64 Doxorubicina 50 mg amp x $ 33,48 $ 9.910,08 Oncológico 65 Doxorubicina Liposomal 20 mg amp x 1 46 $ 1.100,62 $ ,39 Oncológico 66 Doxorubicina Liposomal 20 mg vial x 1 0 $ 2.945,00 $ 0,00 Oncológico 67 Epirubicina 50 mg amp x $ 110,61 $ ,58 Oncológico 68 Eritropoyetina Rec Hum UI liof fco amp x $ 19,47 $ 2.102,76 Oncológico 69 Eritropoyetina Rec Hum UI liof fco amp x 1 52 $ 19,47 $ 1.012,44 Oncológico 70 Eritropoyetina Rec Hum UI liof fco amp x 1 0 $ 11,34 $ 0,00 Oncológico 71 Eritropoyetina Rec Hum UI liof fco amp x 1 0 $ 20,21 $ 0,00 Oncológico 72 Eritropoyetina Rec Hum UI liof fco amp x 1 0 $ 40,64 $ 0,00 Oncológico 73 Eritropoyetina Rec Hum UI liof fco amp x 1 0 $ 40,64 $ 0,00 Oncológico 74 Eritropoyetina Rec Hum UI liof fco amp x $ 22,00 $ 4.664,00 Oncológico 75 Eritropoyetina Rec Hum UI liof fco amp x $ 50,95 $ 6.114,00 Oncológico 76 Eritropoyetina Rec Hum UI liof fco amp x 1 0 $ 74,52 $ 0,00 Oncológico 77 Eritropoyetina Rec Hum UI liof fco amp x 1 0 $ 117,60 $ 0,00 Oncológico 78 Erlotinib 25 mg comp x 30 0 $ 3.184,41 $ 0,00 Oncológico 79 Erlotinib 100 mg comp x 30 3 $ ,45 $ ,35 CUADRO DEFINITIVO LIC. PÚB. 01/2009-6/13

7 Oncológico 80 Erlotinib 150 mg comp x $ 2.927,21 $ ,78 Oncológico 81 Estramustina 140 mg caps x $ 475,68 $ 4.281,08 Oncológico 82 Etoposido 50 mg comp x 20 0 $ 0,00 $ 0,00 Oncológico 83 Etoposido 100 mg comp x 10 0 $ 0,00 $ 0,00 Oncológico 84 Etoposido 100 mg fco amp x $ 6,80 $ 1.313,17 Oncológico 85 Exemestano 25 mg comp x $ 390,16 $ ,63 Oncológico 86 Exemestano 25 mg comp x $ 451,95 $ 8.135,10 Oncológico 87 Fentanilo 25 mg parches x 5 0 $ 0,00 $ 0,00 Oncológico 88 Fentanilo 50 mg parches x 5 4 $ 0,00 $ 0,00 Oncológico 89 Filgrastim 300 mcg fco amp x $ 57,75 $ ,00 Oncológico 90 Filgrastim 300 mcg fco amp.x 5 0 $ 310,00 $ 0,00 Oncológico 91 Filgrastim 300 mcg fco amp x 1 75 $ 110,90 $ 8.317,50 Oncológico 92 Filgrastim 300 mcg fco amp x 5 0 $ 555,00 $ 0,00 Oncológico 93 Filgrastim 480 mcg fco amp x 1 39 $ 190,57 $ 7.432,23 Oncológico 94 Filgrastim 480 mcg fco amp x 5 0 $ 1.025,00 $ 0,00 Oncológico 95 Filgrastim 480 mcg fco amp x 5 0 $ 930,49 $ 0,00 Oncológico 96 Fludarabina 50 mg amp x 1 38 $ 258,00 $ 9.804,00 Oncológico 97 Fludarabina 50 mg amp x 5 0 $ 1.358,50 $ 0,00 Oncológico 98 Fludarabina oral 10 mg comp x 15 0 $ 976,00 $ 0,00 Oncológico 99 Fluorouracilo 500 mg amp x $ 4,60 $ 4.899,00 Oncológico 100 Flutamida 250 mg comp x $ 21,78 $ 2.003,76 Oncológico 101 Fulvestrant 250 mg jga prell x 5 ml 60 $ 2.183,00 $ ,00 Oncológico 102 Gefitinib 250 mg comp x 30 0 $ 9.338,37 $ 0,00 Oncológico 103 Gemcitabina 1 g amp x $ 359,00 $ ,00 Oncológico 104 Gemcitabina 200 mg amp x $ 71,80 $ ,00 Oncológico 105 Gemtuzumab-Ogofamicin 5 mg fco amp x 1 0 $ 9.340,35 $ 0,00 Oncológico 106 Gemtuzumab 5 mg amp 1 0 $ 9.340,35 $ 0,00 Oncológico 107 Goserelin, Acetato 3,6 mg Kit x $ 499,00 $ ,00 Oncológico 108 Granisetron 3 mg amp x $ 208,70 $ ,90 Oncológico 109 Hidroxiurea 500 mg caps x 20 0 $ 11,76 $ 0,00 Oncológico 110 Hidroxiurea 500 mg caps x $ 48,70 $ 292,20 Oncológico 111 Ibritumomab Tioxetan 1,6 mg 0 $ 0,00 $ 0,00 Oncológico 112 Idarrubicina 5 mg. amp x 1 2 $ 151,20 $ 302,40 Oncológico 113 Idarrubicina 10 mg f.a. 28 $ 196,00 $ 5.488,00 Oncológico 114 Ifosfamida 1 g amp x 1 72 $ 19,55 $ 1.407,60 Oncológico 115 Ifosfamida 2 g amp x 1 0 $ 0,00 $ 0,00 Oncológico 116 Inmunocianina 1mg amp x 1 0 $ 202,27 $ 0,00 Oncológico 117 Inmunocianina 10 mg amp x 1 60 $ 1.581,72 $ ,20 CUADRO DEFINITIVO LIC. PÚB. 01/2009-7/13

8 Oncológico 118 Interferon alfa 2 A 3 MUI 0 $ 21,25 $ 0,00 Oncológico 119 Interferon alfa 2 A 4,5 MUI 0 $ 31,90 $ 0,00 Oncológico 120 Interferon alfa 2 A 9 MUI 0 $ 64,00 $ 0,00 Oncológico 121 interferon alfa 2 A 10 MUI 0 $ 0,00 $ 0,00 Oncológico 122 Interferon alfa 2 A 18 MUI 0 $ 0,00 $ 0,00 Oncológico 123 Interferon alfa 2 B 3 MUI 72 $ 14,58 $ 1.049,76 Oncológico 124 Interferon alfa 2 B 5 MUI 42 $ 23,40 $ 982,80 Oncológico 125 Interferon alfa 2 B 10 MUI 400 $ 46,80 $ ,00 Oncológico 126 Interferon alfa 2 B Pegilado 50 mcg 0 $ 0,00 $ 0,00 Oncológico 127 Interferon alfa 2 B Pegilado 80 mcg 0 $ 0,00 $ 0,00 Oncológico 128 Interferon alfa 2 B Pegilado 120 mcg 0 $ 0,00 $ 0,00 Oncológico 129 Interleukina Z 2 mg amp x $ 589,00 $ ,00 Oncológico 130 Irinotecan 100 mg amp x $ 83,98 $ 9.741,68 Oncológico 131 Ixabepilona 45 mg amp x 1 24 $ 4.810,46 $ ,94 Oncológico 132 Lapatinibi 250 mg comp rec x $ 4.066,19 $ ,32 Oncológico 133 Lapatinibi 250 mg comp rec x $ 0,00 $ 0,00 Oncológico 134 Lenograstin 34 MUI amp x 1 + disolvente 0 $ 0,00 $ 0,00 Oncológico 135 Letrozol 2,5 mg comp x $ 33,35 $ 1.834,25 Oncológico 136 Letrozol 2,5 mg comp x $ 583,88 $ 7.590,44 Oncológico 137 Leucovorina 15 mg comp x 10 0 $ 7,22 $ 0,00 Oncológico 138 Leucovorina 50 mg amp x $ 6,68 $ 4.448,88 Oncológico 139 Leuprolide, Acetato 3.75 mg Kit x 1 0 $ 350,00 $ 0,00 Oncológico 140 Leuprolide, Acetato 3.75 mg Kit x 1 29 $ 368,00 $ ,00 Oncológico 141 Leuprolide, Acetato 7,5 mg Kit x 1 0 $ 260,00 $ 0,00 Oncológico 142 Leuprolide, Acetato 7,5 mg Kit x $ 351,99 $ ,68 Oncológico 143 Lomustina caps x 6 2 $ 259,73 $ 519,46 Oncológico 144 Medroxiprogesterona 500 mg amp x 1 0 $ 11,22 $ 0,00 Oncológico 145 Medroxiprogesterona 500 mg caps x 20 0 $ 41,55 $ 0,00 Oncológico 146 Megestrol 40 mg susp x 240 ml 0 $ 0,00 $ 0,00 Oncológico 147 Megestrol 160 mg comp x 30 5 $ 39,65 $ 198,25 Oncológico 148 Melfalano 2 mg comp x $ 135,70 $ 1.764,13 Oncológico 149 Mercaptopurina 50 mg comp x $ 18,49 $ 813,56 Oncológico 150 Mesilato de imatinib 100 mg comp x $ 5.600,00 $ 0,00 Oncológico 151 Mesilato de imatinib 100 mg comp x $ ,00 $ ,00 Oncológico 152 Mesilato de imatinib 400 mg comp x 30 0 $ 3.300,00 $ 0,00 Oncológico 153 Mesilato de imatinib 400 mg comp x $ 8.307,00 $ ,00 Oncológico 154 Mesna 1 gr fco amp x 1 0 $ 0,00 $ 0,00 Oncológico 155 Mesna 200 mg fco amp x $ 29,55 $ 916,05 CUADRO DEFINITIVO LIC. PÚB. 01/2009-8/13

9 Oncológico 156 Mesna 400 mg fco amp x 10 0 $ 52,00 $ 0,00 Oncológico 157 Mesna 400 mg tab 0 $ 0,00 $ 0,00 Oncológico 158 Metilprednisolona 500 mg fco amp x 1 43 $ 36,70 $ 1.578,10 Oncológico 159 Metilprednisona 8 mg comp x $ 13,98 $ 992,58 Oncológico 160 Metilprednisona 40 mg comp x $ 38,70 $ 2.399,40 Oncológico 161 Metotrexato 2,5 mg comp x 50 8 $ 0,00 $ 0,00 Oncológico 162 Metotrexato 7,5 mg comp x 10 0 $ 17,18 $ 0,00 Oncológico 163 Metotrexato 10 mg comp x 10 0 $ 18,54 $ 0,00 Oncológico 164 Metotrexato 15 mg fco amp x 5 0 $ 28,90 $ 0,00 Oncológico 165 Metotrexato 50 mg amp x $ 6,28 $ 973,40 Oncológico 166 Metotrexato 500 mg amp x 1 49 $ 18,53 $ 907,97 Oncológico 167 Metoxaleno caps x 30 5 $ 195,55 $ 977,75 Oncológico 168 Mitomicina 20 mg amp x $ 47,52 $ 5.417,28 Oncológico 169 Mitoxantrona 20 fco amp x 1 31 $ 37,77 $ 1.170,87 Oncológico 170 Molgramostin 150 mcg fco amp x 1 0 $ 0,00 $ 0,00 Oncológico 171 Molgramostin 300 mcg fco amp x 1 0 $ 371,00 $ 0,00 Oncológico 172 Molgramostin 400 mcg fco amp x 1 0 $ 0,00 $ 0,00 Oncológico 173 Morfina 10 mg x 20 comp 0 $ 0,00 $ 0,00 Oncológico 174 Morfina 10 mg x 50 comp 0 $ 0,00 $ 0,00 Oncológico 175 Morfina 30 mg x 20 comp 13 $ 49,90 $ 648,70 Oncológico 176 Morfina 30 mg x 50 comp 3 $ 130,00 $ 390,00 Oncológico 177 Mycobacterium bovis fco am x 4 48 $ 857,15 $ ,33 Oncológico 178 Nilotinib 200 mg cap x 28 0 $ 0,00 $ 0,00 Oncológico 179 Nilotinib 200 mg cap x 56 0 $ 0,00 $ 0,00 Oncológico 180 Nilotinib 200 mg cap x 84 0 $ 0,00 $ 0,00 Oncológico 181 Nilotinib 200 mg cap x $ ,80 $ 0,00 Oncológico 182 Ondansetron 8 mg amp x $ 2,10 $ 6.491,10 Oncológico 183 Ondansetron 8 mg comp x $ 19,80 $ 5.286,60 Oncológico 184 Onicit 0.25 mg iny f a x 5 ml 0 $ 0,00 $ 0,00 Oncológico 185 Oxaliplatino 50 mg amp x 1 66 $ 27,00 $ 1.782,00 Oncológico 186 Oxaliplatino 100 mg amp x $ 44,08 $ ,16 Oncológico 187 Oxicodona 5 mg x 20 comp 0 $ 0,00 $ 0,00 Oncológico 188 Oxicodona 10 mg x 30 comp 10 $ 105,00 $ 1.050,00 Oncológico 189 Oxicodona 20 mg x 30 comp 0 $ 197,96 $ 0,00 Oncológico 190 Oxicodona 20 mg x 30 comp 57 $ 193,34 $ ,38 Oncológico 191 Oxicodona 40 mg x 30 comp 4 $ 275,00 $ 1.100,00 Oncológico 192 Paclitaxel 30 mg amp x 1 19 $ 28,08 $ 533,52 Oncológico 193 Paclitaxel 30 mg amp x 5 0 $ 245,00 $ 0,00 CUADRO DEFINITIVO LIC. PÚB. 01/2009-9/13

10 Oncológico 194 Paclitaxel 100 mg amp x $ 81,82 $ ,62 Oncológico 195 Paclitaxel 150 mg amp x 1 80 $ 95,00 $ 7.600,00 Oncológico 196 Paclitaxel 300 mg fco amp x 1 20 $ 185,51 $ 3.710,20 Oncológico 197 Pamidronato disodico 90 mg amp x $ 36,90 $ 8.856,00 Oncológico 198 Pamidronato disodico 90 mg amp x 1 43 $ 140,00 $ 6.020,00 Oncológico 199 Pemetrexed 500 mg amp x 1 36 $ 5.138,53 $ ,15 Oncológico 200 Pentosan Polisulfato 100 mg caps x $ 631,63 $ 0,00 Oncológico 201 Rituximab 100 mg/10 ml fco amp x 2 54 $ 3.585,08 $ ,12 Oncológico 202 Rituximab 500 mg/50 ml fco amp x $ 9.037,57 $ ,45 Oncológico 203 Sorafenib 200 mg comp x $ ,00 $ ,00 Oncológico 204 Sunitinib 12,5 mg comp x 28 4 $ 5.098,15 $ ,59 Oncológico 205 Sunitinib 25 mg comp x 28 4 $ ,85 $ ,42 Oncológico 206 Sunitinib 50 mg comp x $ ,62 $ ,42 Oncológico 207 Tamoxifeno 20 mg comp. X $ 4,35 $ 4.197,75 Oncológico 208 Tamoxifeno 20 mg comp. X $ 23,00 $ 4.646,00 Oncológico 209 Tamoxifeno 20 mg comp. X $ 64,20 $ 770,34 Oncológico 210 Tegafur + Uracilo 100 mg comp x $ 172,65 $ 2.244,43 Oncológico 211 Tegafur + Uracilo 100 mg comp x $ 739,92 $ 0,00 Oncológico 212 Temozolamida 20 mg x 5 caps 1 $ 289,88 $ 289,88 Oncológico 213 Temozolamida 20 mg x 5 caps 0 $ 720,00 $ 0,00 Oncológico 214 Temozolomida 100 mg caps x 5 48 $ 890,00 $ ,00 Oncológico 215 Temozolomida 100 mg x 5 caps 0 $ 3.532,00 $ 0,00 Oncológico 216 Temozolomida 250 mg caps x 5 7 $ 3.388,00 $ ,00 Oncológico 217 Temozolomida 250 mg x 5 caps 0 $ 8.671,00 $ 0,00 Oncológico 218 Tenipósido 50 mg amp x 10 0 $ 0,00 $ 0,00 Oncológico 219 Thio-Tepa 0 $ 0,00 $ 0,00 Oncológico 220 Tioguanina comp x 25 3 $ 423,44 $ 1.270,31 Oncológico 221 Topotecan 4 mg fco amp x 1 0 $ 61,75 $ 0,00 Oncológico 222 Topotecan 4 mg fco amp x 5 0 $ 151,20 $ 0,00 Oncológico 223 Tramadol 0,5 gr gts x 20 ml 3 $ 47,03 $ 141,09 Oncológico 224 Tramadol 50 mg amp x 3 0 $ 11,28 $ 0,00 Oncológico 225 Tramadol 50 mg amp x 6 0 $ 22,43 $ 0,00 Oncológico 226 Tramadol 50 mg amp x 20 1 $ 0,00 $ 0,00 Oncológico 227 Tramadol comp x $ 39,40 $ 748,60 Oncológico 228 Tramadol comp x 20 1 $ 0,00 $ 0,00 Oncológico 229 Tramadol 100 mg comp x 10 0 $ 50,91 $ 0,00 Oncológico 230 Transretinoico 10 mg comp x $ 814,17 $ 8.141,69 Oncológico 231 Transtuzumab 440 mg vial x $ 9.150,68 $ ,53 CUADRO DEFINITIVO LIC. PÚB. 01/ /13

11 Oncológico 232 Triptorelina 3.75 Kit x 1 0 $ 462,70 $ 0,00 Oncológico 233 Vinblastina 10 mg amp x 1 29 $ 34,51 $ 1.000,67 Oncológico 234 Vincristina 1 mg fco amp x $ 11,30 $ 2.203,50 Oncológico 235 Vinorelbine 10 mg amp x 1 0 $ 71,19 $ 0,00 Oncológico 236 Vinorelbine 50 mg amp x 1 63 $ 139,90 $ 8.813,70 Oncológico 237 Vinorelbine 20 mg caps x 1 8 $ 449,19 $ 3.593,49 Oncológico 238 Vinorelbine 30 mg caps x 1 69 $ 673,78 $ ,80 Oncológico 239 Zoledronico acido 0.4 mg 243 $ 205,00 $ ,00 Oncológico 240 Zoledrónico ácido 0.4 mg 14 $ 332,85 $ 4.659,90 Oncológico 241 Zoledronico acido 0.4 mg 28 $ 903,51 $ ,28 Prodiass 1 Insulina Actrapid HM 100 UI Cart x 5 x 3 ml 13 $ 147,28 $ 1.914,64 Prodiass 2 Insulina Actrapid HM 100 UI Fco x 10 ml 10 $ 46,59 $ 465,90 Prodiass 3 Insulina Actrapid HM 100 UI Novolet Lap x 5 x 3 ml 41 $ 110,41 $ 4.526,81 Prodiass 4 Insulina Apidra Optiset 100 UI Lap x 5 x 3 ml 51 $ 256,94 $ ,94 Prodiass 5 Insulina Betalin CTE 100 UI Fco x 10 ml 30 $ 83,99 $ 2.519,65 Prodiass 6 Insulina Betalin CTE 100 UI Cart x 5 x 3 ml 49 $ 130,70 $ 6.404,43 Prodiass 7 Insulina Betalin HM L 100 UI Fco x 10 ml 0 $ 83,99 $ 0,00 Prodiass 8 Insulina Betalin NPH 100 UI Cart x 5 x 3 ml 338 $ 133,25 $ ,26 Prodiass 9 Insulina Betalin NPH 100 UI Fco x 10 ml 122 $ 92,17 $ ,76 Prodiass 10 Insulina Betasint BOV CTE 100 UI Fco x 10 ml 0 $ 49,11 $ 0,00 Prodiass 11 Insulina Betasint BOV NPH 100 UI Fco x 10 ml 0 $ 49,11 $ 0,00 Prodiass 12 Insulina Betasint BOV NPH 80 UI Fco x 10 ml 55 $ 44,02 $ 2.421,10 Prodiass 13 Insulina Betasint POR CTE 100 UI Cart x 5 x 3 ml 0 $ 0,00 $ 0,00 Prodiass 14 Insulina Betasint POR CTE 100 UI Fco x 10 ml 0 $ 60,58 $ 0,00 Prodiass 15 Insulina Betasint POR CTE 80 UI Fco x 10 ml 6 $ 52,55 $ 315,29 Prodiass 16 Insulina Betasint POR NPH 100 UI Cart x 5 x 3 ml 0 $ 0,00 $ 0,00 Prodiass 17 Insulina Betasint POR NPH 100 UI Fco x 10 ml 0 $ 69,71 $ 0,00 Prodiass 18 Insulina Betasint POR NPH 80 UI Fco x 10 ml 10 $ 57,28 $ 572,76 Prodiass 19 Insulina Humalog HM 100 UI Cart x 5 x 3 ml 39 $ 251,04 $ 9.790,37 Prodiass 20 Insulina Humalog HM 100 UI Fco x 10 ml 4 $ 125,49 $ 501,97 Prodiass 21 Insulina Humalog Mix UI Cart x 5 x 3 ml 2 $ 251,04 $ 502,07 Prodiass 22 Insulina Humalog Mix UI Cart x 5 x 3 ml 0 $ 251,04 $ 0,00 Prodiass 23 Insulina Humulin HM 70/30 Cart x 5 x 3 ml 11 $ 138,28 $ 1.521,07 Prodiass 24 Insulina Humulin HM 70/30 Fco x 10 ml 5 $ 87,92 $ 439,60 Prodiass 25 Insulina Humulin HM NPH 100 UI Cart x 5 x 3 ml 234 $ 138,28 $ ,40 Prodiass 26 Insulina Humulin HM NPH 100 UI Fco x 10 ml 109 $ 27,00 $ 2.943,00 Prodiass 27 Insulina Humulin HM R 100 UI Cart x 5 x 3 ml 16 $ 138,28 $ 2.212,47 Prodiass 28 Insulina Humulin HM R 100 UI Fco x 10 ml 5 $ 27,00 $ 135,00 CUADRO DEFINITIVO LIC. PÚB. 01/ /13

12 Prodiass 29 Insulina Insulatard HM 100 UI Fco x 10 ml 113 $ 46,59 $ 5.264,67 Prodiass 30 Insulina Insulatard HM 100 UI Flex Pen Lap x 5 x 3 ml 2206 $ 151,29 $ ,74 Prodiass 31 Insulina Insulatard HM 100 UI Penfill Cart x 5 x 3 ml 76 $ 145,97 $ ,72 Prodiass 32 Insulina Insuman HM N 100 UI Cart x 5 x 3 ml 25 $ 124,49 $ 3.112,19 Prodiass 33 Insulina Insuman HM N 100 UI Vial x 1 x 5 ml 0 $ 42,79 $ 0,00 Prodiass 34 Insulina Insuman HM R 100 UI Cart x 5 x 3 ml 4 $ 115,10 $ 460,39 Prodiass 35 Insulina Insuman HM R 100 UI Vial x 1 x 5 ml 0 $ 39,57 $ 0,00 Prodiass 36 Insulina Lantus Analogo Fco x 10 ml 5 $ 197,57 $ 987,86 Prodiass 37 Insulina Lantus Penfill cart x 5 x 3 ml 475 $ 296,59 $ ,64 Prodiass 38 Insulina Lantus Solostar 100 UI/ml lap.prellx5x3ml 621 $ 296,59 $ ,29 Prodiass 39 Insulina Levemir Detemir Flex Pen Lap x 5 x 3 ml 776 $ 309,15 $ ,40 Prodiass 40 Insulina Novomix 30 Analogo Flex Pen Lap x 5 x 3 ml 1111 $ 278,14 $ ,54 Prodiass 41 Insulina Novorapid HM 100 UI Flex Pen Lap x 5 x 3 ml 767 $ 276,36 $ ,12 Prodiass 42 Insulina Novorapid HM 100 UI Penfill Cart x 5 x 3 ml 20 $ 272,25 $ 5.445,00 Prodiass 43 Exenatida 10 mcg iny prell x 1 x 2,4 ml 3 $ 619,76 $ 1.859,29 Prodiass 44 Glibenclamida 5 mg comp x $ 4,47 $ 9.230,55 Prodiass 45 Glibenclamida 5 mg comp x 60 0 $ 9,10 $ 0,00 Prodiass 46 Glicazida 30 mg comp x $ 20,02 $ 6.686,38 Prodiass 47 Glicazida 80 mg comp x $ 15,66 $ 1.205,82 Prodiass 48 Glimepirida 2 mg comp x $ 19,53 $ 1.620,94 Prodiass 49 Glimepirida 4 mg comp x $ 34,45 $ ,84 Prodiass 50 Glipizida 5 mg comp x $ 22,21 $ 2.176,58 Prodiass 51 Glucagen Hypokit 74 $ 155,54 $ ,80 Prodiass 52 Gluco 15 sobres x 3 0 $ 0,00 $ 0,00 Prodiass 53 Glucoten tab x $ 14,16 $ 1.755,92 Prodiass 54 Metformina 500 comp x $ 5,18 $ ,86 Prodiass 55 Metformina 850 comp x $ 9,55 $ ,75 Prodiass 56 Metformina 1000 comp x $ 12,00 $ 1.740,00 Prodiass 57 Metformina XR comp x $ 12,82 $ 3.846,00 Prodiass 58 Metformina + Glibenclamida 250/1,25 comp x $ 9,95 $ 567,03 Prodiass 59 Metformina + Glibenclamida 500/2,5 comp x $ 10,45 $ 2.811,83 Prodiass 60 Metformina + Glibenclamida 500/5 comp x $ 10,37 $ ,92 Prodiass 61 Metformina + Glimepirida 500/2 comp x $ 30,29 $ 575,47 Prodiass 62 Metformina + Glimepirida 850/4 comp x $ 50,63 $ 3.240,32 Prodiass 63 Metformina + Glimepirida 1000/4 comp x 30 2 $ 58,57 $ 117,14 Prodiass 64 Metformina + Rosiglitazona 500/2 comp x $ 25,23 $ 630,79 Prodiass 65 Metformina + Rosiglitazona 500/4 comp x $ 46,78 $ 1.683,96 Prodiass 66 Metformina + Sitagliptina 500/50 comp x $ 67,59 $ 1.487,08 CUADRO DEFINITIVO LIC. PÚB. 01/ /13

13 Prodiass 67 Pioglitazona 30 mg comp x $ 47,14 $ 2.498,45 Prodiass 68 Pioglitazona 45 mg comp x $ 34,50 $ 483,00 Prodiass 69 Repaglinida 0,5 mg comp x $ 21,00 $ 231,00 Prodiass 70 Repaglinida 1 mg comp x $ 21,00 $ 231,00 Prodiass 71 Repaglinida 2 mg comp x 30 0 $ 21,00 $ 0,00 Prodiass 72 Roziglitazona 4 mg comp x $ 32,88 $ 4.570,32 Prodiass 73 Roziglitazona 8 mg comp x $ 32,88 $ 6.576,00 Prodiass 74 Sitagliptina 100 mg comp x $ 118,47 $ ,38 Prodiass 75 Sitagliptina 25 mg comp x 28 0 $ 118,47 $ 0,00 Prodiass 76 Sitagliptina 50 mg comp x 28 7 $ 118,47 $ 829,29 Prodiass 77 Agujas BD Micro Fine 31 G 5 mm x $ 53,02 $ 212,06 Prodiass 78 Agujas BD Micro Fine 31 G 8 mm x $ 53,02 $ 4.082,23 Prodiass 79 Agujas Novo Fine 6 mm x G/32 G 1294 $ 42,65 $ ,33 Prodiass 80 Agujas Novo Fine 8 mm x G/32 G 76 $ 62,06 $ 4.716,54 Prodiass 81 Jeringas y Agujas p/aplicación de Insulina x $ 0,27 $ 1.004,40 Prodiass 82 Lancetas Accu Check Active x $ 57,45 $ ,70 Prodiass 83 Lancetas Accu Check Active x $ 9,88 $ 622,30 Prodiass 84 Lancetas Accu Check Performa Multiclick x $ 30,87 $ 7.192,91 Prodiass 85 Lancetas Accu Check Performa Multiclick x $ 9,93 $ ,53 Prodiass 86 Tiras Reactivas Accu Check Active x $ 87,33 $ ,80 Prodiass 87 Tiras Reactivas Accu Check Performa x $ 85,00 $ ,00 Prodiass 88 Tiras Reactiva p/medición cuantitativa de glucemia 900 $ 0,01 $ 9,00 CUADRO DEFINITIVO LIC. PÚB. 01/ /13

Medications most likely to be seen in primary care

Medications most likely to be seen in primary care Hazardous Medicines The majority of medicines are not classed as hazardous. The only medicinal products that are automatically deemed to be hazardous are cytotoxic and cytostatic medicines. There is no

More information

Review of the List of High-Cost Medicines used by the Dominican Republic s Protected Diseases Program and Planning of Purchases for 2015

Review of the List of High-Cost Medicines used by the Dominican Republic s Protected Diseases Program and Planning of Purchases for 2015 Review of the List of High-Cost Medicines used by the Dominican Republic s Protected Diseases Program and Planning of Purchases for 2015 July 2014 Review of the List of High-Cost Medicines Used by the

More information

Guideline for Insulin Therapeutic Review in patients with Type 2 Diabetes

Guideline for Insulin Therapeutic Review in patients with Type 2 Diabetes Diabetes Sans Frontières Guideline for Insulin Therapeutic Review in patients with Type 2 Diabetes 1. Introduction This guideline has been developed in order to support practices to undertake insulin therapeutic

More information

Hydration, IV Infusions, Injections and Vaccine Charge Process

Hydration, IV Infusions, Injections and Vaccine Charge Process There are a number of items to be considered when billing for the Nursing service to perform drug therapy, the charge process is divided into three specific groups of codes and processes. 1. Hydration

More information

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet 02300699 1 tablet daily. Complera 200/25/300 mg tablet 02374129 1 tablet daily

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet 02300699 1 tablet daily. Complera 200/25/300 mg tablet 02374129 1 tablet daily HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ emtricitabine/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ emtricitabine/

More information

LISTA NACIONAL DE MEDICAMENTOS ESENCIALES LINAME 2014-2016 PRECIOS REFERENCIALES 2014 ACTUALIZADA 19/12/2014

LISTA NACIONAL DE MEDICAMENTOS ESENCIALES LINAME 2014-2016 PRECIOS REFERENCIALES 2014 ACTUALIZADA 19/12/2014 LISTA NACIONAL DE MEDICAMENTOS ESENCIALES LINAME 2014-2016 PRECIOS REFERENCIALES 2014 ACTUALIZADA Co di go Medicamento Forma Farmacéutica Concentración J 05 01 Abacavir Comprimido 300 mg J05AF06 2,62 A

More information

Safe use of insulin e- learning module

Safe use of insulin e- learning module Safe use of insulin e- learning module Page 1 Introduction Insulin is a hormone produced by the beta cells in the pancreas, it is released when blood glucose levels are raised for example after a meal.

More information

PRODUCT INN REFERENCE AUTHORIZATION Omnitrope

PRODUCT INN REFERENCE AUTHORIZATION Omnitrope PRODUCT INN REFERENCE AUTHORIZATION Omnitrope Genotropin 12/04/2006 somatropin Valtropin (W/D) Humatrope 24/04/2006 Abseamed Binocrit Epoetina alfa hexal Retacrit Silapo Biograstim Filgrastim ratiopharm

More information

Development of the market of special care drugs

Development of the market of special care drugs Forecast Special Care Drugs Development of the market of special care drugs IGES Institut Berlin, April 6th 21 I G E S I n s t i t ut G m bh w w w. i ges.de Friedrichstraße 18 1117 Berlin Germany +49 3

More information

GROUP 1 CARCINOGEN, CHEMOTHERAPY WASTE & OTHER HAZARDOUS DRUG DISPOSAL NAME APPROVAL DATE EFFECTIVE DATE REVISION RENEE MICHEL 05/01/11 0

GROUP 1 CARCINOGEN, CHEMOTHERAPY WASTE & OTHER HAZARDOUS DRUG DISPOSAL NAME APPROVAL DATE EFFECTIVE DATE REVISION RENEE MICHEL 05/01/11 0 GROUP 1 CARCINOGEN, CHEMOTHERAPY WASTE & OTHER HAZARDOUS DRUG DISPOSAL NAME APPROVAL DATE EFFECTIVE DATE REVISION RENEE MICHEL 05/01/11 0 INTRODUCTION Prior to commencing work involving carcinogens, chemotherapeutics

More information

DPC 20151120 040321010 ONDANSETRONE SETOFILM*6FILMS ORODISP 4MG A04AA01 040321046 ONDANSETRONE SETOFILM*6FILMS ORODISP 8MG A04AA01

DPC 20151120 040321010 ONDANSETRONE SETOFILM*6FILMS ORODISP 4MG A04AA01 040321046 ONDANSETRONE SETOFILM*6FILMS ORODISP 8MG A04AA01 MINSAN Principio Attivo DESCRIZIONE ATC/CODICE COMPLEMENTA RE 040321010 ONDANSETRONE SETOFILM*6FILMS ORODISP 4MG A04AA01 040321046 ONDANSETRONE SETOFILM*6FILMS ORODISP 8MG A04AA01 027612074 ONDANSETRONE

More information

Type 2 Diabetes Medications: SGLT2 Inhibitors

Type 2 Diabetes Medications: SGLT2 Inhibitors Type 2 Diabetes Medications: SGLT2 Inhibitors SGLT2 inhibitors are a class of type 2 diabetes medications used along with diet and exercise to lower blood glucose How are they taken? SGLT2 inhibitors is

More information

insulin & diabetes What is insulin? Why must it be injected? What if I have to go on to insulin? Are there different types of insulin?

insulin & diabetes What is insulin? Why must it be injected? What if I have to go on to insulin? Are there different types of insulin? Talking diabetes No.24 insulin & diabetes Insulin injections are required when the body produces little or no insulin, as with type 1 diabetes. They are also required for some people with type 2 diabetes

More information

insulin & diabetes What is insulin? Why must it be injected? What if I have to go on to insulin? Are there different types of insulin?

insulin & diabetes What is insulin? Why must it be injected? What if I have to go on to insulin? Are there different types of insulin? Talking diabetes No.24 insulin & diabetes Insulin injections are required when the body produces little or no insulin, as with type 1 diabetes. They are also required for some people with type 2 diabetes

More information

Cost Differences in Cancer Care Across Settings

Cost Differences in Cancer Care Across Settings Cost Differences in Cancer Care Across Settings August 2013 THE MORAN COMPANY 1 Cost Differences in Cancer Care Across Settings In a prior memorandum, we presented evidence documenting the growing share

More information

INTRODUCTION TO INSULIN

INTRODUCTION TO INSULIN INTRODUCTION TO INSULIN This section will give you some practical advice about using insulin. Your diabetes team will answer any particular questions that you may have e.g. dose of insulin. TYPES OF INSULIN

More information

MASCC/ESMO Antiemetic Guideline 2013

MASCC/ESMO Antiemetic Guideline 2013 MASCC/ESMO Antiemetic Guideline 2013 Multinational Association of Supportive Care in Cancer Organizing and Overall Meeting Chairs: Richard J. Gralla, MD Fausto Roila, MD Maurizio Tonato, MD Jørn Herrstedt,

More information

HIV 1. A reference guide for prescription HIV-1 medications

HIV 1. A reference guide for prescription HIV-1 medications HIV 1 A reference guide for prescription HIV-1 medications Several different kinds of antiretroviral drugs are currently used to treat HIV-1 infection. These medicines are the ones most commonly used in

More information

Insulin. and diabetes. What is insulin? Who needs to inject insulin? Why must it be injected? What if I have to go on to insulin?

Insulin. and diabetes. What is insulin? Who needs to inject insulin? Why must it be injected? What if I have to go on to insulin? Insulin What is insulin? and diabetes Insulin is a hormone made by special cells, called beta cells, in the pancreas. When we eat, insulin is released into the blood stream where it helps to move glucose

More information

Approximate Cost Reference List i for Antihyperglycemic Agents

Approximate Cost Reference List i for Antihyperglycemic Agents Alpha Glucosidase Inhibitor Acarbose (Glucobay ) Biguanides Metformin (Glucophage, generic) Metformin ER (Glumetza ) Approximate Cost Reference List i for Antihyperglycemic Agents Incretin Agents - DPP-4

More information

insulin & diabetes Talking diabetes No.24 Revised 2012

insulin & diabetes Talking diabetes No.24 Revised 2012 Talking diabetes No.24 Revised 2012 insulin & diabetes Insulin injections are required when the body produces little or no insulin, as with type 1 diabetes. They are also required for some people with

More information

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium insulin glulisine for subcutaneous injection 100 units/ml (Apidra ) No. (298/06) Sanofi Aventis 4 August 2006 The Scottish Medicines Consortium (SMC) has completed its assessment

More information

Onset Peak Duration Comments

Onset Peak Duration Comments Rapid- Acting 5-15 minutes 0.5-3 hours 3-5 hours Meal should be available before administering, ideally taking within 10 minutes of eating). Good in refrigerator (36-46 F) until expiration date. Protect

More information

ONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place)

ONCE ONLY GLUCAGON and Fast Acting Glucose gel (PGD) For nurse administration under Patient Group Direction (Trust wide PGD in place) ADULT INSULIN PRERIPTION AND BLOOD GLUCOSE MONITORING CHART Ward CONSULTANT DATE OF ADMISSION Please affix Patient s label here Ward Ward.../...year PATIENT NAME....... DATE OF BIRTH... NHS NUMBER.......

More information

Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2

Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2 Ministry of Health, Malaysia 2010 First published March 2011 Perkhidmatan Diabetes dan Endokrinologi Kementerian Kesihatan Malaysia Practical guide to Insulin Therapy in Type 2 Diabetes Mellitus Quick

More information

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication

More information

Chapter 7: Lung Cancer

Chapter 7: Lung Cancer Chapter 7: Lung Cancer Contents Chapter 7: Lung Cancer... 1 Small Cell... 2 Good PS + Limited stage... 2 Cisplatin/etoposide... 2 Concurrent chemotherapy + XRT... 2 Good / Intermediate PS... 2 Carboplatin

More information

CLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies

CLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies Insulins CLASS OBJECTIVES Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies INVENTION OF INSULIN 1921 The first stills used to make insulin

More information

Covered California s 2016 Formularies

Covered California s 2016 Formularies Covered California s 2016 Formularies An analysis of the drugs per tier in all 12 health plans that are available for treating and preventing HIV (pp 1 24) and for treating hepatitis B (pp 26 37) and hepatitis

More information

DIABETES - INSULIN INITIATION - BACKGROUND INFORMATION (1)

DIABETES - INSULIN INITIATION - BACKGROUND INFORMATION (1) DIABETES - INSULIN INITIATION - BACKGROUND INFORMATION (1) KEY PRINCIPLES Many patients with Type 2 diabetes will require insulin therapy. In the UKPDS over 50% of patients by 6 years required additional

More information

DPC AGGIORNATO AL 25/04/2011 PER SPECIALITA'

DPC AGGIORNATO AL 25/04/2011 PER SPECIALITA' DPC AGGIORNATO AL 2/04/20 PER SPECIALITA' 03682029 ABILIFY CPR. 0MG. N0AX2 ARIPIPRAZOLO 2 0368203 ABILIFY CPR. MG. N0AX2 ARIPIPRAZOLO 3 0368207 ABILIFY CPR. MG. N0AX2 ARIPIPRAZOLO 4 03682094 ABILIFY CPR.

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: PC (CO) - Insulin Delivery Systems Therapeutic Class: Hormones and Synthetic Substitutes Therapeutic Sub-Class: Insulin Delivery Systems Client: CO Approval Date:

More information

Insulin Dependent Diabetes Trust

Insulin Dependent Diabetes Trust Insulin Dependent Diabetes Trust Looking After Your Insulin Updated September 2013 Registered Company Number 3148360 Registered Charity No 1058284 It is over 85 years since the discovery of insulin and

More information

Workshop A Tara Kadis

Workshop A Tara Kadis Workshop A Tara Kadis Considerations/barriers in decision making about insulin verses GLP-1 use in people with type 2 diabetes Which Insulin regimes should we consider? Diabetes is a progressive multi-system

More information

PATIENT ASSISTANCE PROGRAMS

PATIENT ASSISTANCE PROGRAMS PATIENT ASSISTANCE PROGRAMS Definitions SAP Class I Class II BC Cancer Agency Health Canada Special Access Program Reimbursed for active cancer or approved treatment or approved indication only Reimbursed

More information

TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS

TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS The aim of the Diabetes level 2 service is to provide a high quality service for safe initiation and optimization of injectable therapy within GP networks.

More information

Pharmaceutical Risk Sharing Agreements C. Bernie Good MD MPH Department of Veterans Affairs June 2014

Pharmaceutical Risk Sharing Agreements C. Bernie Good MD MPH Department of Veterans Affairs June 2014 Pharmaceutical Risk Sharing Agreements C. Bernie Good MD MPH Department of Veterans Affairs June 2014 Objectives Describe concept of Risk-Share Agreements Describe types of agreements Identify specific

More information

HIV & Malignancy Potential for Drug Drug Interactions

HIV & Malignancy Potential for Drug Drug Interactions HIV & Malignancy Potential for Drug Drug Interactions Kay Seden Aims and Outline Mechanisms of drug drug interactions associated with antiretrovirals and treatment for malignancy Examples of interactions

More information

Potential Interactions Between Antineoplastics and Antiretrovirals

Potential Interactions Between Antineoplastics and Antiretrovirals Potential Interactions Between Antineoplastics and Antiretrovirals Antiretroviral Pharmacokinetic Characteristics (summary): Protease Inhibitors (PIs) atazanavir (Reyataz ) 1, darunavir (Prezista ) 2,

More information

An estimated 280 Australians develop diabetes every day. It is Australia s fastest-growing chronic disease.

An estimated 280 Australians develop diabetes every day. It is Australia s fastest-growing chronic disease. Diabetes and insulin Summary Even with the help of your doctor and diabetes nurse educator, it may take a while to find the right insulin dose to reduce your blood glucose to your target levels. Insulin

More information

Drug Treatment Program Update

Drug Treatment Program Update Drug Treatment Program Update As of May 211 Drug Treatment Program Update A key component of the Centre s mandate is to monitor the impact of HIV/AIDS on British Columbia. The Centre provides essential

More information

Educational Objectives. Type 2 Diabetes: a progressive condition. Insulin Delivery Devices. Insulin we may wait too long

Educational Objectives. Type 2 Diabetes: a progressive condition. Insulin Delivery Devices. Insulin we may wait too long Educational Objectives Insulin Delivery Devices James Bennett RPh, FACA, CDE Director of Clinical Services at James Bennett Apothecary Corinth Mississippi After viewing this program, participants should

More information

Allegato 1 - Farmaci sottoposti a piano terapeutico LEGENDA PT GENERICO. piano terapeutico con template generico. PT SPECIFICO + nome principio attivo

Allegato 1 - Farmaci sottoposti a piano terapeutico LEGENDA PT GENERICO. piano terapeutico con template generico. PT SPECIFICO + nome principio attivo Allegato 1 - Farmaci sottoposti a piano terapeutico LEGENDA PT GENERICO PT SPECIFICO + nome principio attivo PT AIFA CONTINUITA' TERAPEUTICA H-T piano terapeutico con template generico piano terapeutico

More information

Parenteral Dosage of Drugs

Parenteral Dosage of Drugs Chapter 11 Parenteral Dosage of Drugs Parenteral Route of administration other than gastrointestinal Intramuscular (IM) Subcutaneous (SC) Intradermal (ID) IV Parenteral Most medications prepared in liquid

More information

PRONTUARIO TERAPEUTICO OSPEDALIERO

PRONTUARIO TERAPEUTICO OSPEDALIERO Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo Alessandria Via Venezia, 16 15100 ALESSANDRIA Tel. 0131 206111 www.ospedale.al.it [email protected] C.F. P.I. 01640560064 S.C. FARMACIA

More information

THE HAZARDOUS WASTE (ENGLAND AND WALES) REGULATIONS 2005

THE HAZARDOUS WASTE (ENGLAND AND WALES) REGULATIONS 2005 THE HAZARDOUS WASTE (ENGLAND AND WALES) REGULATIONS 2005 Interim Guidance for the NHS Hospital Sector for England and Wales and Information for Scotland Additional paper copies may be requested by contacting:

More information

Glycaemic Control in Adults with Type 1 Diabetes

Glycaemic Control in Adults with Type 1 Diabetes Glycaemic Control in Adults with Type 1 Diabetes Aim(s) and objective(s) This document aims to provide guidance on good clinical practice in managing glycaemic control in adult patients with Type 1 Diabetes

More information

Coverage and Pricing. of Drugs That Can Be Covered Under. Part B and Part D

Coverage and Pricing. of Drugs That Can Be Covered Under. Part B and Part D Coverage and Pricing Elizabeth Hargrave NORC at the University of Chicago Jack Hoadley of Drugs That Can Be Covered Under Part B and Part D Jennifer Thompson Georgetown University MedPAC A study conducted

More information

Insulin pen start checklist

Insulin pen start checklist Insulin pen start checklist Topic Instruction Date & Initials 1. Cognitive Assessment 2. Insulin Delivery loading appropriate mixing priming shot dialing up dose delivery of insulin 3. Insulin type/action

More information

Comparative cardiovascular morbidity and mortality in patients taking different insulin regimes for type 2 diabetes: A systematic review

Comparative cardiovascular morbidity and mortality in patients taking different insulin regimes for type 2 diabetes: A systematic review Comparative cardiovascular morbidity and mortality in patients taking different insulin regimes for type 2 diabetes: A systematic review Search Question: What is the impact of insulin type, does and regime

More information

Insulin onset, peak and duration of action

Insulin onset, peak and duration of action Insulin onset, peak and duration of action Insulin was first discovered in the early 190 s. Before then, diabetes could not be treated. Insulin was then taken from cow and pig pancreases, but nearly all

More information

Information for Patients

Information for Patients Information for Patients Guidance for Diabetic Persons having bowel preparation for a flexible sigmoidoscopy or a colonoscopy or a combined gastroscopy and colonoscopy This guidance is provided to assist

More information

Drugs covered under Medicare Part B or Part D

Drugs covered under Medicare Part B or Part D LABEL_NAME GENERIC_NAME MESSAGE GEMZAR INJ 1 GM GEMCITABINE HCL FOR INJ 1 GM ALIMTA INJ 500MG PEMETREXED DISODIUM FOR IV SOLN 500 MG (BASE EQUIV) FUNGIZONE INJ 50MG AMPHOTERICIN B FOR INJ 50 MG KYTRIL

More information

INSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE

INSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE INSULIN INITIATION IN TYPE 2 DIABETES IN PRIMARY CARE We welcome feedback on this policy and the way it operates. We are interested to know of any possible or actual adverse impact that this policy/procedure

More information

D( desired ) Q( quantity) X ( amount ) H( have)

D( desired ) Q( quantity) X ( amount ) H( have) Name: 3 (Pickar) Drug Dosage Calculations Chapter 10: Oral Dosage of Drugs Example 1 The physician orders Lasix 40 mg p.o. daily. You have Lasix in 20 mg, 40 mg, and 80 mg tablets. If you use the 20 mg

More information

Cara Liday, PharmD, CDE Associate Professor, Idaho State University Clinical Pharmacist and CDE, InterMountain Medical Center Pocatello, ID The planners and presenter have disclosed no conflict of interest,

More information

2014-06-10 Approved Bendamustine - Treatment of relapsed low grade NHL in patients unable to receive standard therapy 2014-05-

2014-06-10 Approved Bendamustine - Treatment of relapsed low grade NHL in patients unable to receive standard therapy 2014-05- Sub. Sub. Status -06-16 Approved Lenalidomide - 2nd line treatment of multiple myeloma in patients who have contraindications to the use of bortezomib -06-16 Approved Lenalidomide - 2nd line treatment

More information

North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV

North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV Of North Carolina s marketplace insurance offerings, only Blue Cross Blue Shield s plans are potentially affordable

More information

Lead Clinician(S) (DATE) Approved by Diabetes Directorate on: Approved by Medicines Safety Group on: This guideline should not be used after end of:

Lead Clinician(S) (DATE) Approved by Diabetes Directorate on: Approved by Medicines Safety Group on: This guideline should not be used after end of: Guideline for members of the diabetes team and dietetic department for advising on insulin dose adjustment and teaching the skills of insulin dose adjustment to adults with type 1 or type 2 diabetes mellitus

More information

Insulin Pens & Improving Patient Adherence

Insulin Pens & Improving Patient Adherence Insulin Pens & Improving Patient Adherence Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute Kip Benko, MD FACEP Asst Clinical Professor University of Pittsburgh School

More information

A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration

A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration of nurse A new insulin order form should be completed for subsequent changes to type of insulin and/or frequency of administration 1. Check times for point of care meter blood glucose testing. Pre-Breakfast

More information

Resident s Guide to Inpatient Diabetes

Resident s Guide to Inpatient Diabetes Resident s Guide to Inpatient Diabetes 1. All patients with diabetes of ANY TYPE, regardless of reason for admission, must have a Hemoglobin A1C documented in the medical record within 24 hours of admission

More information

Guide for Storage of Insulin

Guide for Storage of Insulin Guide for Storage of Insulin Every effort is made to assure the accuracy of the attached information. This information is not intended to be used as a tool to prescribe medication or provide other clinical

More information

Helpful HIV Medication Tables for Pharmacists

Helpful HIV Medication Tables for Pharmacists 861837_Pharmguide.qxd 2/5/14 12:55 PM Page 1 Helpful HIV Medication Tables for Pharmacists New York/New Jersey AIDS Education & Training Center (AETC) www.nynjaetc.org Winter 2014 861837_Pharmguide.qxd

More information

Marketplace Health Plans Template Assessment Tool October 2014

Marketplace Health Plans Template Assessment Tool October 2014 Marketplace Health Plans Template Assessment Tool October 2014 Beginning in January 2015, state and federal Marketplaces (aka exchanges) will again offer a range of insurance plans called qualified health

More information

GENERAL INSTRUCTIONS FOR COMPLETING THE HIV TEST FORM

GENERAL INSTRUCTIONS FOR COMPLETING THE HIV TEST FORM GENERA INSTRUCTIONS FOR COMPETING THE This form is designed to be read by an Optical Character Recognition (OCR) scanner. The legibility of this form depends on the quality of the a hand written and selected

More information

education Insulin delivery devices Paper Current insulin preparations Discovery of insulin and key developments in preparations

education Insulin delivery devices Paper Current insulin preparations Discovery of insulin and key developments in preparations Paper 2009 Royal College of Physicians of Edinburgh Insulin delivery devices 1 AJ Graveling, 2 EA McIntyre 1 Specialty Registrar; 2 Consultant, Department of Diabetes & Endocrinology, Monklands Hospital,

More information

Clinical Guideline Diabetes management during surgery (adults)

Clinical Guideline Diabetes management during surgery (adults) Clinical Guideline Diabetes management during surgery (adults) Standard 8 of the National Service Framework for Diabetes states that all children, young people and adults with diabetes admitted to hospital,

More information

PRONTUARIO TERAPEUTICO AZIENDALE A.O. LEGNANO

PRONTUARIO TERAPEUTICO AZIENDALE A.O. LEGNANO A.T.C. PRINCIPIO ATTIVO DOSAGGIO TOTALE della forma farmaceutica FORMA FARMACEUTICA A- APPARATO GASTROINTESTINALE A01AB03 clorexidina 200MG/ML 150 ML SOLUZ. MUCOSA ORALE A01AB09 miconazolo 2% GEL ORALE

More information

NLPDP Coverage Status Table December 2015. Initial and maintenance fills are limited to a maximum 30 days

NLPDP Coverage Status Table December 2015. Initial and maintenance fills are limited to a maximum 30 days Coverage Table December 2015 02238646 282 MEP TABLET OPEN No 500 0.2103 02234510 282 TABLET OPEN No 500 0.0726 02238645 292 TABLET OPEN No 50 0.1877 02192691 3TC 10 MG/ML SOLUTION OPEN No 240 0.3454 02192683

More information

CDC occupation Codes used to code ( map ) facility locations

CDC occupation Codes used to code ( map ) facility locations CDC occupation Codes used to code ( map ) facility locations CDC (occupation) Code BLS SOC (2000)* CDC (occupation) Code BLS SOC (2000)* ATT-Attendant/orderly 31-1012 CLA-Clerical/administrative CNA-Nurse

More information

Policies and Procedures. I.D. Number: 1044

Policies and Procedures. I.D. Number: 1044 Policies and Procedures Title: HAZARDOUS DRUGS (Non-Chemotherapy) ADMINISTRATION AND PRECAUTIONS I.D. Number: 1044 Authorization: [X] SHR Nursing Practice Committee Source: Nursing Date Revised: November

More information

Surgery and Procedures in Patients with Diabetes

Surgery and Procedures in Patients with Diabetes Surgery and Procedures in Patients with Diabetes University Hospitals of Leicester NHS Trust DEFINITIONS Minor Surgery and Procedures: expected to be awake, eating and drinking by the next meal, total

More information

Small cell Lung cancer New Chemotherapy options. Nicolas Mach, MD,PD

Small cell Lung cancer New Chemotherapy options. Nicolas Mach, MD,PD Small cell Lung cancer New Chemotherapy options Nicolas Mach, MD,PD > 40 negative Phase III trials List of unsucessful drugs Pemetrexed, imatinib, bevacizumab, bcl-2 antagonist, ASCT, CASE PRESENTATION

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: PC - Apidra, Levemir Therapeutic Class: Hormones and Synthetic Substitutes Therapeutic Sub-Class: Antidiabetic Agents Client: CA, CO, NV, OK, OR, WA and AZ Approval

More information

Diabetes Treatments: Options for Insulin Delivery. Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute

Diabetes Treatments: Options for Insulin Delivery. Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute Diabetes Treatments: Options for Insulin Delivery Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute Diabetes 21 million people in the U.S. have diabetes $132 billion each

More information

DIABETES MEDICATION INSULIN

DIABETES MEDICATION INSULIN Section Three DIABETES MEDICATION INSULIN This section will tell you: About insulin. How to care and store your insulin. When to take your insulin. Different ways of taking insulin. WHAT IS INSULIN? Insulin

More information

Insulin: A Powerful Weapon in the Diabetic Arsenal. Diana Cowell, PharmD PGY-1 Pharmacy Resident

Insulin: A Powerful Weapon in the Diabetic Arsenal. Diana Cowell, PharmD PGY-1 Pharmacy Resident Insulin: A Powerful Weapon in the Diabetic Arsenal Diana Cowell, PharmD PGY-1 Pharmacy Resident Objectives Identify the mechanism of action of insulin Describe the onset and duration for the various types

More information

Type 1 and Type 2 Diabetes in Pediatric Practice

Type 1 and Type 2 Diabetes in Pediatric Practice Type 1 and Type 2 Diabetes in Pediatric Practice Chirag R. Kapadia, MD Division of Endocrinology, Phoenix Children s Hospital Clinical Assistant Professor, U of A College of Medicine Presentation outline

More information

The safe use of insulin and you

The safe use of insulin and you Ambulatory Care & Local Networks The safe use of insulin and you Information for patients The right insulin The right dose The right way The right time 3 Insulin treatment improves the quality of life

More information

Natural history of disease progression

Natural history of disease progression 경희의대 내분비내과 오 승 준 Contents 1 2 3 인슐린 치료의 어려움 Natural history of disease progression Macrovascular complications Microvascular complications b-cell function Insulin resistance Blood glucose Prevention Treatment

More information

THE ROYAL CORNWALL HOSPITALS NHS TRUST RESPONSE TO INFORMATION REQUEST. Date Request Received: 03 August 2015 FOI Ref: 947

THE ROYAL CORNWALL HOSPITALS NHS TRUST RESPONSE TO INFORMATION REQUEST. Date Request Received: 03 August 2015 FOI Ref: 947 FREEDOM OF INFORMATION ACT 2000 THE ROYAL CORNWALL HOSPITALS NHS TRUST RESPONSE TO INFORMATION REQUEST Date Request Received: 03 August 2015 FOI Ref: 947 Requested Information For the Royal Cornwall Hospitals

More information

ASWCS Policy for the Treatment of Extravasation Injury

ASWCS Policy for the Treatment of Extravasation Injury ASWCS Policy for the Treatment of Extravasation Injury Extravasation of Cytotoxic Drugs Introduction 1. The purpose of this policy is to inform practitioners of their responsibilities in relation to preventing

More information

Inspira (Vineland/Woobury) Open Clinical Trials as of December 16, 2015

Inspira (Vineland/Woobury) Open Clinical Trials as of December 16, 2015 Inspira (Vineland/Woobury) Open Clinical Trials as of December 16, 2015 Advanced Refractory Solid Tumors or Lymphomas ECOG-ACRIN EAY131 (NCI CIRB) Targeted Therapy Directed by Genetic Testing in Treating

More information

Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes

Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes PL Detail-Document #300128 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER January 2014 Initiation and Adjustment of Insulin Regimens for Type

More information

J_Code To NDC Billing Cross Reference Guide

J_Code To NDC Billing Cross Reference Guide J_Code To Billing Cross Reference Guide J0129 Injection, abatacept, 10 mg GENERIC J0129 UN 250 MG 250 MG 25 ABATACEPT/MALTOSE J0150 6 MG Injection adenosine 6 MG GENERIC J0150 ML 3 MG/ML 3 MG ML 1 0.5

More information

Comprehensive Case Management Reassessment

Comprehensive Case Management Reassessment Comprehensive Case Management Reassessment Reassessment Date: Date of previous Assessment/Reassessment: Name: Client ID # Address: If Reassessment early or late explain: Current HIV Status: Asymptomatic

More information

How to adjust your insulin if taken two or three times daily. To change the insulin dose, you will need to know:

How to adjust your insulin if taken two or three times daily. To change the insulin dose, you will need to know: What to do if your results are too high or too low The target range for your blood glucose results is from to 8 mmol/l - aim to have four out of every five blood glucose results in this range. If three

More information

Injectable Insulin During Pregnancy

Injectable Insulin During Pregnancy Injectable Insulin During Pregnancy What is insulin? Insulin is a hormone made by the pancreas. The pancreas is a small organ that lies behind and below the stomach. Insulin allows the food you eat to

More information

LISTADO DE MEDICAMENTOS CON SUSTANCIAS INCLUIDAS EN RESOLUCION DOPAJE VIGENTE

LISTADO DE MEDICAMENTOS CON SUSTANCIAS INCLUIDAS EN RESOLUCION DOPAJE VIGENTE LISTADO DE MEDICAMENTOS CON SUSTANCIAS INCLUIDAS EN RESOLUCION DOPAJE VIGENTE Medicamentos con sustancias descritas en la Resolución de 18 de diciembre de 2014 de la Presidencia del Consejo Superior de

More information